參考文獻(xiàn)/References:
[1] Kim Y J,Baek J H,Ha E J,et al.Cystic versus predominantly cystic thyroid nodules:efficacy of ethanol ablation and analysis of relates factors[J]. Eur Radiol,2012,22(7):1573-1578.
[2] 中華醫(yī)學(xué)會(huì)內(nèi)分泌分會(huì),中華醫(yī)學(xué)會(huì)外科學(xué)分會(huì)分內(nèi)泌學(xué)組,中國(guó)抗癌協(xié)會(huì)頭頸腫瘤專業(yè)委員會(huì),等.甲狀腺結(jié)節(jié)和分化型甲狀腺癌診治指南[J]. 中華內(nèi)分泌代謝雜志,2012,28(10):779-797.
[3] Popoveniuc G,Jonklaas J.Thyroid nodules [J].Med Clin North Am,2012,96(2):329-349.
[4] Gharib H,Papini E,Garber J R,et al.AACE/ACE/AME medical guidelines for clinical practice for the diagnosis and management of thyroid nodules 2016 update [J].Endocr Pract,2016,22(5):622-639.
[5] Kim Y J,Baek J H,Ha E J,et al.Cystic versus predominantly cystic thyroid nodules:efficacy of ethanol ablation and analysis of related factors[J].Eur Radiol,2012,22(7):1573-1578.
[6] 黃家慶,魏奕娜,陳小曼,等.超聲引導(dǎo)下甲狀腺囊腫抽吸硬化治療的應(yīng)用價(jià)值[J].中國(guó)醫(yī)藥研究,2018, 8(5):214-216.
[7] Haugen B R,Alexander E K,Bible K C,et al.2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2016,26(1):372-381.
[8] 袁華芳,李泉水,趙齊羽,等.超聲引導(dǎo)下聚桂醇硬化治療甲狀腺囊性病變的療效及安全性分析[J].中國(guó)超聲醫(yī)學(xué)雜志,2016,32(8):677-680.
[9] 孫醫(yī)學(xué),蘇蕾,都曉英,等.超聲引導(dǎo)下聚桂醇和平陽(yáng)霉素治療靜脈畸形效果比較[J].中國(guó)超聲醫(yī)學(xué)雜志,2015,31(11):1035-1037.
[10] Sparchez Z,Radu P,Zaharie F,et al.Percutaneous treat-ment of symptomatic non-parasitic hepatic cysts.Initial experience with single-session sclerotherapy with polidocanol [J].Med Ultrason,2014,16(3):222-228.
[11] 陳英銀,劉銳洪.超聲介入聚桂醇硬化治療甲狀腺囊腫的療效評(píng)價(jià)[J].實(shí)用醫(yī)學(xué)影像雜志,2017,18(6):488-490.
[12] 洪運(yùn)虎,王桂林,勞海燕,等.超聲引導(dǎo)下3種劑量聚桂醇硬化治療甲狀腺囊腫療效比較[J].華夏醫(yī)學(xué),2018,31(2):117-119.
[13] LV G,Chen S,Li B,et al.Efficacy assessment of newly developed open-window intervention needles for the treatment of cystic thyroid nodules that cannot be aspirated [J].Thyroid,2014,24(6):1212-1217.
[14] 陳志江,王龍,黃怡靜,等.良性甲狀腺囊腫超聲引導(dǎo)聚桂醇硬化治療效果及其相關(guān)因素分析[J].南方醫(yī)科大學(xué)學(xué)報(bào),2016,32(12):1694-1699.
相似文獻(xiàn)/References:
[1]尹冠群,曾艷,周戎君,等.超聲光散射成像對(duì)乳腺腫瘤診斷價(jià)值分析[J].福建醫(yī)藥雜志,2017,39(4):127.
[2]盧希,林樹(shù)英,林芩,等.超聲引導(dǎo)下喉上神經(jīng)內(nèi)支阻滯對(duì)喉罩全麻后咽喉痛的影響[J].福建醫(yī)藥雜志,2017,39(4):137.
[3]鄭婉靜,陳國(guó)忠.圍術(shù)期超聲引導(dǎo)下星狀神經(jīng)節(jié)阻滯的研究進(jìn)展[J].福建醫(yī)藥雜志,2017,39(4):155.
[4]聶立雄 邱全明 張其旺 吳曉丹.羅哌卡因復(fù)合右美托咪定用于腹橫肌平面阻滯對(duì)剖宮產(chǎn)術(shù)后靜脈鎮(zhèn)痛效果的影響[J].福建醫(yī)藥雜志,2017,39(5):29.
[5]李學(xué)山.超聲引導(dǎo)下腰叢坐骨神經(jīng)阻滯在髖關(guān)節(jié)置換術(shù)的應(yīng)用效果觀察[J].福建醫(yī)藥雜志,2017,39(5):75.
[6]陳琳.超聲引導(dǎo)下肌間溝臂叢神經(jīng)阻滯在上肢清創(chuàng)手術(shù)中的應(yīng)用[J].福建醫(yī)藥雜志,2017,39(5):111.
[7]吳道明 朱 琳 林 蕓 張麗華
吳松松 林 寧.光散射成像預(yù)測(cè)乳腺浸潤(rùn)性癌腋窩淋巴結(jié)轉(zhuǎn)移的作用[J].福建醫(yī)藥雜志,2019,41(05):16.
WU Daoming,ZHU Lin,LIN Yun,et al.Assessing prediction of axillary lymph node status in invasive breast carcinoma by using diffuse optical tomography[J].FUJIAN MEDICAL JOURNAL,2019,41(01):16.
[8]朱藝霞,王明虹.超聲引導(dǎo)下頭部周圍神經(jīng)阻滯在開(kāi)顱手術(shù)中的應(yīng)用[J].福建醫(yī)藥雜志,2021,43(02):18.
ZHU Yixia,WANG Minghong.Application of ultrasound-guided peripheral nerve block in craniotomy[J].FUJIAN MEDICAL JOURNAL,2021,43(01):18.
[9]涂文劭,鄭艇,陳江湖,等.術(shù)前超聲引導(dǎo)髂筋膜間隙阻滯持續(xù)鎮(zhèn)痛在老年髖部骨折患者中的應(yīng)用[J].福建醫(yī)藥雜志,2021,43(03):4.
TU Wenshao,ZHENG Ting,CHEN Jianghu,et al.Application of preoperative ultrasound-guided fascia iliaca compartment block for continuous analgesia in elderly patients with hip fracture[J].FUJIAN MEDICAL JOURNAL,2021,43(01):4.
[10]黃潔,王翠蘭.染色體微陣列分析技術(shù)在超聲異常胎兒產(chǎn)前遺傳學(xué)診斷中的應(yīng)用價(jià)值[J].福建醫(yī)藥雜志,2022,44(04):5.
HUANG Jie,WANG Cuilan.Application value of chromosome microarray analysis in prenatal genetic diagnosis of abnormal fetus detected by ultrasound[J].FUJIAN MEDICAL JOURNAL,2022,44(01):5.